Step-dose of muzolimine at different stages of chronic renal failure: comparison with furosemide.
The authors have compared the clinical and metabolic effects of two high ceiling diuretics, muzolimine (M) and furosemide (F), by i.v. and oral routes in 40 patients classified in four groups with different degrees of renal failure. The study demonstrated a more pronounced effectiveness of M than F by oral administration, while it appeared equal to F when given i.v. The urine volume and Na+ excretion were significantly increased during M treatment compared to oral F in each group. Calcium urinary excretion was reduced with M while P was increased compared with F. BUN, creatinine and uric acid were temporarily increased in the 3rd and 4th groups, probably due to extracellular fluid volume contraction, associated also with transient change in GFR. M at a lower dosage than F has demonstrated an effective diuretic response irrespective the degree of renal impairment. From its pharmacological properties, M appears a safe and active diuretic agent, particularly at a high dosage in patients with severe renal failure, and is notable for its lack of important side effects.
D001794:Blood Pressure / Q000187:drug effects; D001806:Blood Urea Nitrogen; D001835:Body Weight / Q000187:drug effects; D002118:Calcium / Q000652:urine; D003404:Creatinine / Q000097:blood; D004231:Diuresis / Q000187:drug effects; D004573:Electrolytes / Q000097:blood; D005665:Furosemide / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D009156:Muzolimine / Q000627:therapeutic use*; D009318:Natriuresis / Q000187:drug effects; D011720:Pyrazoles / Q000627:therapeutic use*; D013997:Time Factors; D014527:Uric Acid / Q000652:urine
D004573:Electrolytes; D011720:Pyrazoles; D009156:Muzolimine; D014527:Uric Acid; D005665:Furosemide; D003404:Creatinine; D002118:Calcium